Значение дисфункции правого желудочка, правожелудочково-артериального сопряжения при хронической сердечной недостаточности: роль эхокардиографии

В обзоре рассматриваются клиническое и прогностическое значение эхокардиографических методов оценки функции правого желудочка и правожелудочково-артериального сопряжения, преимущества и недостатки эхокардиографии в сравнении с другими инструментальными исследованиями у пациентов с хронической сердечной недостаточностью.

правый желудочек, правожелудочково-артериальное сопряжение, хроническая сердечная недостаточность, эхокардиография, right ventricle, right ventricular - pulmonary artery coupling, chronic heart failure, echocardiography

1. Pleister A., Kahwash R., Haas G. et al. Echocardiography and heart failure: a glimpse of the right heart. Echocardiography 2015; 32: 95-107. DOI: 10.1111/echo.12678.

2. Dutta T., Aronow W. S. Echocardiographic evaluation of the right ventricle: Clinical implications. Clin Cardiol 2017; 40: 542-543. DOI: 10.1002/clc.22694.

3. Dell'Italia L.J. The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 1991; 16: 653-720.

4. Markley R. R., Ali A., Potfay J. et al. Echocardiographic Evaluation of the Right Heart. J Cardiovasc Ultrasound 2016; 24: 183-190. DOI: 10./4250/jcu.2016.24.3.183.

5. Damiano R. J., La Follette P., Cox, J. L. et al. Significant left ventricular contribution to right ventricular systolic function. Am J Physiol 1991; 261: 1514-1524. DOI: 10.1152/ajpheart.1991.261.5.H1514.

6. Pinsky M. R. The right ventricle: interaction with the pulmonary circulation. Crit Care 2016; 20: 266. DOI: 10.1186/ s13054-016-1440-0.

7. Voelkel N. F., Quaife R. A., Leinwand L. A. et al. Right ventricular function and failure. Circulation 2006; 114: 1883-1891. DOI: 10.1161/CIRCULATIONAHA.106.632208.

8. Klima U. P., Guerrero J. L., Vlahakes G.J. Myocardial perfusion and right ventricular function. Ann Thorac Cardiovasc Surg 1999; 5: 74-80.

9. Левчук М. Н., Бондаренко Б. Б. Правый желудочек и меж-желудочковое взаимодействие. Артериальная гипертензия 2010; 16: 321-324

10. Rudski L. G., Lai W. W., Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography: endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J American Society Echocardiography 2010; 23: 685-713. DOI: 10.1016/j.echo.2010.05.010.

11. Rain S., Handoko M. L., Trip P. et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 2013; 128: 2016-2025, 2011-2010. DOI: 10.1161/CIRCULATIONAHA.113.001873

12. Naeije R., Manes A. The right ventricle in pulmonary arterial hypertension. Eur Respir Rev 2014; 23: 476-487. DOI: 10.1183/09059180.00007414

13. van de Veerdonk M. C., Kind T., Marcus J. T. et al. Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. J Am Coll Cardiol 2011; 58: 2511-2519. DOI: 10.1016/j.jacc.2011.06.068

14. Borgdorff M. A., Bartelds B., Dickinson M. G. et al. Distinct loading conditions reveal various patterns of right ventricular adaptation. Am J Physiol Heart Circ Physiol 2013; 305: 354-364.

15. Guazzi M., Bandera F., Pelissero G. et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 2013; 305: 1373-1381. DOI: 10.1152/ajpheart.00157.2013

16. Zakeri R., Mohammed S. F. Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction. Current heart failure reports 2015; 12: 295-301. DOI: 10.1007/s11897-015-0267-3

17. de Groote P. Right ventricular systolic function in heart failure: A long story but still the same question. Archives of cardiovascular diseases 2016; 109: 227. DOI: 10.1016/j.acvd.2016.02.001

18. Ghio S., Gavazzi A., Campana C. et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. Journal of the American College of Cardiology 2001; 37: 183-188.

19. de Groote P., Millaire A., Foucher-Hossein C. et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998; 32: 948-954.

20. Zornoff L. A., Skali H., Pfeffer M. A. et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol 2002; 39: 1450-1455. DOI. org/10.1016/S0735-1097(02)01804-1

21. Damy T., Kallvikbacka-Bennett A., Goode K. et al. Prevalence of, associations with, and prognostic value of tricuspid annular plane systolic excursion (TAPSE) among out-patients referred for the evaluation of heart failure. J Card Fail 2012; 18: 216-225. DOI: 10.1016/j.cardfail.2011.12.003

22. de Groote P., Fertin M., Goéminne C. et al. Right ventricular systolic function for risk stratification in patients with stable left ventricular systolic dysfunction: comparison of radionuclide angiography to echoDoppler parameters. European heart journal 2012; 33: 2672-2679. DOI: 10.1093/eurheartj/ehs080

23. Melenovsky V., Kotrc M., Borlaug B. A. et al. Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. Am Coll Cardiol 2013; 62: 1660-1670. DOI: 10.1016/j.jacc.2013.06.046

24. Iacoviello M., Citarelli G., Antoncecchi V. et al. Right Ventricular Longitudinal Strain Measures Independently Predict Chronic Heart Failure Mortality. Echocardiography 2016; 33: 992-1000.

25. Barbieri A., Bursi F., Grigioni F. et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011; 32: 751-759. DOI: 10.1093/eurheartj/ehq294

26. Ghio S., Guazzi M., Scardovi A. B. et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. European Journal of Heart Failure 2016; 19: 873-879. DOI: 10.1002/ejhf.664

27. Merlo M., Gobbo M., Stolfo D. et al. The Prognostic Impact of the Evolution of RV Function in Idiopathic DCM. JACC Cardiovasc Imaging 2016; 9: 1034-1042.

28. Thibault G. E. Clinical problem-solving. Studying the classics. N Engl J Med 1995; 333: 648-652.

29. Meyer P., Filippatos G. S., Ahmed M. I. et al. Effects of right ventricular ejection fraction on outcomes in chronic systolic heart failure. Circulation 2010; 121: 252-258. DOI: 10.1161/CIRCULATIONAHA.109.887570

30. Rosenkranz S., Gibbs J. S., Wachter R. et al. Left ventricular heart failure and pulmonary hypertension. Eur Heart J 2016; 37: 942-954. DOI: 10.1093/eurheartj/ehv512

31. Guazzi M., Villani S., Generati G. et al. Right ventricular contractile reserve and pulmonary circulation uncoupling during exercise challenge in heart failure: pathophysiology and clinical phenotypes. JACC: Heart Failure 2016; 4: 625-635. DOI: 10.1016/j.jchf.2016.03.007

32. Bursi F., McNallan S. M., Redfield M. M. et al. Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol 2012; 59: 222-231. DOI: 10.1016/j.jacc.2011.06.076.

33. Shah A. M., Shah S.J., Anand I. S. et al. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. Circ Heart Fail 2014; 7: 104-115. DOI: 10.1161/CIRCHEARTFAILURE.113.000887

34. Pfeffer M. A., Claggett B., Assmann S. F. et al. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation 2015; 131: 34-42. DOI: 10.1161/CIRCULATIONAHA.114.013255

35. Poels E. M., da Costa Martins P. A., van Empel V. P. Adaptive capacity of the right ventricle: why does it fail? Am J Physiol Heart Circ Physiol 2015; 308: 803-813. DOI: 10.1152/ajpheart.00573.2014

36. Borlaug B. A., Kane G. C., Melenovsky V., Olson T. P. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. European heart journal 2016; 37: 3294-3295. DOI: 10.1093/eurheartj/ehw241

37. Mohammed S. F., Hussain I., AbouEzzeddine O. F. et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 2014; 130: 2310-2320. DOI. org/10.1161/CIRCULATIONAHA.113.008461

38. Morris D. A., Gailani M., Vaz Perez A. et al. Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. J Am Soc Echocardiogr 2011; 24: 886-897. DOI: 10.1016/j. echo. 2011.04.005

39. Burke M. A., Katz D. H., Beussink L. et al. Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2014; 7: 288-299. DOI: 10.1161/CIRCHEARTFAILURE.113.000854

40. Shah A. M., Claggett B., Sweitzer N. K. et al. Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial. Circ Heart Fail 2014; 7: 740-751. DOI: 10.1161/CIRCHEARTFAILURE.114.001583

41. Lam C. S., Roger V. L., Rodeheffer R.J. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009; 53: 1119-1126. DOI: 10.1016/j.jacc.2008.11.051

42. Leung C. C., Moondra V., Catherwood E., Andrus B. W. Prevalence and risk factors of pulmonary hypertension in patients with elevated pulmonary venous pressure and preserved ejection fraction. Am J Cardiol 2010; 106: 284-286. DOI: 10.1016/j.amjcard.2010.02.039

43. Ichiki H., Oketani N., Hamasaki S. et al. Effect of right ventricular apex pacing on the Tei index and brain natriuretic peptide in patients with a dual-chamber pacemaker. Pacing Clin Electrophysiol 2006; 29: 985-990. D0I: 10.1111/j.1540-8159.2006.00474.x

44. Topilsky Y., Khanna A., Le Tourneau T. et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging 2012; 5: 314-323. DOI: 10.1161/CIRCIMAGING.111.967919

45. Melenovsky V., Hwang S.J., Lin G. et al. Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014; 35: 3452-3462. DOI: 10.1093/eurheartj/ehu193

46. Lam C. S., Carson P. E., Anand I. S. et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 2012; 5: 571-578. DOI: 10.1161/CIRCHEARTFAILURE.112.970061

47. Andersen M.J., Hwang S.-J., Kane G. C. et al. Enhanced Pulmonary Vasodilator Reserve and Abnormal Right VentricularCLINICAL PERSPECTIVE. Circulation: Heart Failure 2015; 8: 542-550. DOI: 10.1161/CIRCHEARTFAILURE.114.002114

48. Kubba S., Davila C. D., Forfia P. R. Methods for Evaluating Right Ventricular Function and Ventricular-Arterial Coupling. Prog Cardiovasc Dis 2016; 59: 42-51. DOI: 10.1016/j.pcad.2016.06.001

49. Hummel Y. M., Bugatti S., Damman K. et al. Functional and hemodynamic cardiac determinants of exercise capacity in patients with systolic heart failure. Am J Cardiol 2012; 110: 1336-1341. DOI: 10.1016/j.amjcard.2012.06.039

50. Smarz K., Zaborska B., Jaxa-Chamiec T. et al. Right ventricular dysfunction and exercise capacity after inferior (posterior) wall acute myocardial infarction. Am J Cardiol 2012; 110: 784-789. DOI: 10.1016/j.ijcard.2016.07.088

51. Tadic M., Cuspidi C., Suzic-Lazic J. et al. Is there a relationship between right-ventricular and right atrial mechanics and functional capacity in hypertensive patients? J Hypertens 2014; 32: 929-937.

52. Mullens W., Abrahams Z., Francis G. S. et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53: 589-596. DOI: 10.1016/j.jacc.2008.05.068

53. La W. W., Gauvreau K., Rivera E. S. et al. Accuracy of guideline recommendations for two-dimensional quantification of the right ventricle by echocardiography. Int J Cardiovasc Imaging 2008; 24: 691-698. DOI: 10.1007/s10554-008-9314-4

54. Mehra M. R. Fat, Cachexia, and the Right Ventricle in Heart Failure. Journal of the American College of Cardiology 2013; 62: 1671.

55. Voelkel N. F., Bogaard H.J., Gomez-Arroyo J. The need to recognize the pulmonary circulation and the right ventricle as an integrated functional unit: facts and hypotheses (2013 Grover Conference series). Pulmonary circulation 2015; 5: 81-89. DOI/10.1086/679702

56. Ryan J. J., Tedford R. J. Diagnosing and treating the failing right heart. Current opinion in cardiology 2015; 30: 292. DOI: 10.1097/HCO.0000000000000164

57. Sundereswaran L., Nagueh S. F., Vardan S. et al. Estimation of left and right ventricular filling pressures after heart transplantation by tissue Doppler imaging. Am J Cardiol 1998; 82: 352-357.

58. Dandel M., Hetzer R. Echocardiographic assessment of the right ventricle: Impact of the distinctly load dependency of its size, geometry and performance. International Journal of Cardiology 2016; 221: 1132-1142. DOI: 10.10/16/j.ijcard.2016.07.014

59. Damy T., Viallet C., Lairez O. et al. Comparison of four right ventricular systolic echocardiographic parameters to predict adverse outcomes in chronic heart failure. Eur J Heart Fail 2009; 11: 818-824. DOI: 10.1093/eurjhf/hfp111

60. Morgan J. A., Paone G., Nemeh H. W. et al. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant 2013; 32: 398-403. DOI: 10.1016/ j. healun. 2012.12.018

61. Sabe M. A., Sabe S. A., Kusunose K. et al. Predictors and Prognostic Significance of Right Ventricular Ejection Fraction in Patients With Ischemic Cardiomyopathy. Circulation 2016; 134: 656-665. DOI: 10.1161/CIRCULATIONAHA.116.022339

62. Miller W. L., Grill D. E., Borlaug B. A. Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. JACC Heart Fail 2013; 1: 290-299. DOI: 10.1016/j.jchf.2013.05.001

63. Tampakakis E., Leary P.J., Selby V. N. et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 2015; 3: 9 16. DOI: 10.1016/j.jchf.2014.07.010

64. Dupont M., Mullens W., Skouri H. N. et al. Prognostic role of pulmonary arterial capacitance in advanced heart failure. Circ Heart Fail 2012; 5: 778-785. DOI.org/10.1161/CIRCHEARTFAILURE.112.968511

65. Pellegrini P., Rossi A., Pasotti M. et al. Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. Chest 2014; 145: 1064-1070. DOI: 10.1378/chest.13-1510

66. Dragu R., Rispler S., Habib M. et al. Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension. Eur J Heart Fail 2015; 17: 74-80. DOI: 10.1002/ejhf.192

67. Tei C., Dujardin K. S., Hodge D. O. et al. Doppler echocardiographic index for assessment of global right ventricular function. J Am Soc Echocardiogr 1996; 9: 838-847.

68. Anavekar N. S., Skali H., Bourgoun M. et al. Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study). Am J Cardiol 2008; 101: 607-612. DOI: 10.1016/ j.amjcard.2007.09.115

69. Smarz K., Zaborska B., Jaxa-Chamiec T. et al. Right ventricular systolic function as a marker of prognosis after ST-elevation inferior myocardial infarction 5-year follow-up. International Journal of Cardiology 2016; 221: 549-553. DOI.org/10.1016/j.ijcard.2016.07.088

70. Venner C., Selton-Suty C., Huttin O. et al. Right ventricular dysfunction in patients with idiopathic dilated cardiomyopathy: Prognostic value and predictive factors. Arch Cardiovasc Dis 2016; 109: 231-241. DOI.org/10.1016/j.acvd.2015.10.006

71. Rodrigues A. C., Cordovil A., Monaco C. G. et al. Assessing prognosis of pulmonary embolism using tissue-Doppler echocardiography and brain natriuretic peptide. Einstein (Sao Paulo) 2013; 11: 338-344.

72. Hu K., Liu D., Stork S. et al. Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation. J Card Fail 2017; 23: 434-443.

73. Olson J., Samad B. A., Alam M. The prognostic significance of right ventricular tissue Doppler parameters in patients with left ventricular systolic heart failure: an observational cohort study. Heart 2012; 98: 1142-1145. DOI: 10.1136/heartjnl-2012-301785

74. Hsu S., Houston B. A., Tampakakis E. et al. Right ventricular functional reserve in pulmonary arterial hypertension. Circulation 2016; 133 (24): 2413-2422. DOI: 10.1161/cIRCULATIONAHA.116.022082

75. Brewis M.J., Bellofiore A., Vanderpool R. R. et al. Imaging right ventricular function to predict outcome in pulmonary arterial hypertension. International journal of cardiology 2016; 218: 206-211. DOI: 10.1016/j.ijcard.2016.05.015

76. Naeije R., D'Alto M. The Diagnostic Challenge of Group 2 Pulmonary Hypertension. Prog Cardiovasc Dis 2016; 59: 22-29. DOI: 10.1016/j.pcad.2016.05.003

77. Gerges M., Gerges C., Pistritto A.-M. et al. Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. American journal of respiratory and critical care medicine 2015; 19: 1234-1246. DOI: 10.1164/rccm.201503-0529OC

78. Ghio S., Temporelli P. L., Klersy C. et al. Prognostic relevance of a non-invasive evaluation of right ventricular function and pulmonary artery pressure in patients with chronic heart failure. Eur J Heart Fail 2013; 15: 408-414. DOI: 10.1093/eurjhf/hfs208

79. Guazzi M., Dixon D., Labate V. et al. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes. JACC: Cardiovascular Imaging 2017; 10 (10 Pt B): 1211-1221. DOI: 10.1016/j.jcmg.2016.12.024

80. Robert Naeije. Right Ventriculo-Arterial Coupling Structure/ Function Paradox. Right Heart Failure Summit, Boston, 2012.

81. Cameli M., Righini F. M., Lisi M. et al. Comparison of right versus left ventricular strain analysis as a predictor of outcome in patients with systolic heart failure referred for heart transplantation. Am J Cardiol 2013; 112: 1778-1784. DOI: 10.1016/j.amjcard.2013.07.046

82. Hardegree E. L., Sachdev A., Villarraga H. R. et al. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol 2013; 111: 143-148. DOI: 10.1016/j.amjcard.2012.08.061

83. Iacoviello M., Monitillo F., Citarelli G. et al. Right ventriculo-arterial coupling assessed by two-dimensional strain: A new parameter of right ventricular function independently associated with prognosis in chronic heart failure patients. International Journal of Cardiology 2017; 241: 318-321. DOI: 10.1016/j.ijcard.2017.04.051

84. Vizzardi E., D'Aloia A., Caretta G. et al. Long-term prognostic value of longitudinal strain of right ventricle in patients with moderate heart failure. Hellenic J Cardiol 2014; 55: 150-155.

85. Frea S., Pidello S., Bovolo V. et al. Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure. European journal of heart failure 2016; 18: 564-572. DOI: 10.1002/ejhf.504

86. Aronson D., Darawsha W., Atamna A. et al. Pulmonary hypertension, right ventricular function, and clinical outcome in acute decompensated heart failure. Journal of cardiac failure 2013; 19: 665-671. DOI: 10.1016/j.cardfail.2013.08.007

87. Aronson D., Burger A. J. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail 2010; 16: 541-547. DOI: 10.1016/j.cardfail.2010.02.001

88. Yu H. C., Sanderson J. E. Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure. Clin Cardiol 1999; 22: 504-512.

89. Gorter T. M., Hoendermis E. S., van Veldhuisen D. J. et al. Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail 2016; 18: 1472-1487. DOI: 10.1002/ejhf.630

90. Schwarz K., Singh S., Dawson D., Frenneaux M. P. Right ventricular function in left ventricular disease: pathophysiology and implications. Heart, Lung and Circulation 2013; 22: 507-511.

91. Borlaug B. A., Nishimura R. A., Sorajja P. et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010; 3: 588-595. DOI: 10.1161/cIRCHEARTFAILURE.109.930701

92. Lewis G. D., Murphy R. M., Shah R. V. et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 2011; 4: 276-285. DOI: 10.1161/CIRCHEARTFAILURE.110.959437

93. Naeije R., Vonk Noordegraaf A., Kovacs G. Exercise-induced pulmonary hypertension: at last! Eur RespirJ 2015; 46: 583-586. DOI: 10.1183/09031936.00061015

94. Robbins I. M., Hemnes A. R., Pugh M. E. et al. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 2014; 7: 116-122. DOI: 10.1161/CIRCHEARTFAILURE.113.000468

95. Galie N., Humber, M., Vachiery J. L. et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (iSHLt). Eur Heart J 2016; 37: 67-119. DOI: 10.1093/eurheartj/ehv317

96. Gerges C., Gerges M., Lang M. B. et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion" pulmonary hypertension. Chest 2013; 143: 758-766. DOI: 10.1378/chest.12-1653

97. Hussain I., Mohammed S. F., Forfia P. R. et al. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE. Circulation: Heart Failure 2016; 9 (4): e002729. DOI: 10.1161/CIRCHEARTFAILURE.115.002729

98. Guazzi M., Vicenzi M., Arena R., Guazzi M. D. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail 2011; 4: 8-17. DOI: 10.1161/CIRCHEARTFAILURE.110.944694

99. Bonderman D., Ghio S., Felix S. B. et al. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study. Circulation 2013; 128: 502-511. DOI: 10.1161/CIRCULATIONAHA.113.001458

100. Borlaug B. A., Koepp K. E., Melenovsky V. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2015; 66: 1672-1682. DOI: 10.1016/j.jacc.2015.07.067

101. Kaye D. M., Marwick T. H. Impaired Right Heart and Pulmonary Vascular Function in HFpEF: Time for More Risk Markers? 2017. JACC Cardiovasc Imaging. 2017; 10: 1222-1224. DOI: 10.1016/j.jcmg.2016.12.023

102. Lewis G. D., Bossone E., Naeije R. et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 2013; 128: 1470-1479. DOI: 10.1161/CIRCULATIONAHA.112.000667

103. Opitz C. F., Hoeper M. M., GibbsJ. S. et al. Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. J Am Coll Cardiol 2016; 68: 368-378. DOI: 10.1016/ j.jacc.2016.05.047

104. Hoendermis E. S., Liu L. C., Hummel Y. M. et al. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Eur Heart J 2015; 36: 2565-2573. DOI: 10.1093/eurheartj/ehv336

105. Guazz, M., Vicenzi M., Arena R., Guazzi M. D. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011; 124: 164-174. DOI: 10.1161/CIRCULATIONAHA.110.983866

106. Bonderman D., Pretsch I., Steringer-Mascherbauer R. et al. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. Chest 2014; 146: 1274-1285. DOI: 10.1378/chest.140106

107. Simon M. A., Vanderpool R. R., Nouraie M. et al. Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction. JCI Insight 2016; 1 (18): e89620. DOI: 10.1172/jci.insight. 89620